Mary L. Bolofo

The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

Heather Giles, P. Leff, Mary L. Bolofo et al. · British Journal of Pharmacology · 1989 · 195 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Inhibition of endothelium‐dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence

Graeme R. Martin, Mary L. Bolofo, Heather Giles · British Journal of Pharmacology · 1992 · 70 citations · Full text

Medicine, Pharmacology, Experimental Pharmacology +14

Characterization of a 5‐HT_1B receptor on CHO cells: functional responses in the absence of radioligand binding

Heather Giles, Stuart J. Lansdell, Mary L. Bolofo et al. · British Journal of Pharmacology · 1996 · 64 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

A comparative study of the prostanoid receptor profile of 9α11β‐prostaglandin F₂ and prostaglandin D₂

Heather Giles, Mary L. Bolofo, S.J. Lydford et al. · British Journal of Pharmacology · 1991 · 24 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Synthesis of hexahydrocyclopentimidazol-2-(1H)-one derivatives displaying selective DP-receptor agonist properties

Paul Barraclough, Mary L. Bolofo, Heather Giles et al. · Bioorganic & Medicinal Chemistry · 1996 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14